Practical Geriatrics ›› 2023, Vol. 37 ›› Issue (6): 626-629.doi: 10.3969/j.issn.1003-9198.2023.06.022
Previous Articles Next Articles
Received:
2022-07-25
Online:
2023-06-20
Published:
2023-06-30
CLC Number:
[1] ARVANITAKIS Z, SHAH R C, BENNETT D A. Diagnosis and management of dementia: review [J]. JAMA, 2019, 322(16): 1589-1599. [2] LISKO I, KULMALA J, ANNETORP M, et al. How can dementia and disability be prevented in older adults: where are we today and where are we going? [J]. J Intern Med, 2021, 289(6): 807-830. [3] JIA J, WEI C, CHEN S, et al. The cost of Alzheimer's disease in China and re-estimation of costs worldwide [J]. Alzheimers Dement, 2018, 14(4): 483-491. [4] 2022 Alzheimer's disease facts and figures[J]. Alzheimers Dement,2022,18(4):700-789. [5] SCLAN S G, REISBERG B. Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity, and ordinality [J]. Int Psychogeriatr, 1992, 4 (1): 55-69. [6] O'BRYANT S E, LACRITZ L H, HALL J, et al. Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database [J]. Arch Neurol, 2010, 67(6): 746-749. [7] MORRIS J C. The Clinical Dementia Rating (CDR): current version and scoring rules [J]. Neurology, 1993, 43(11): 2412-2414. [8] OLAZARÁN J, REISBERG B, CLARE L, et al. Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy [J]. Dement Geriatr Cogn Disord, 2010, 30(2): 161-178. [9] SIKKES S A M, TANG Y, JUTTEN R J, et al.Toward a theory-based specification of non-pharmacological treatments inaging and dementia: focused reviews and methodological recommendations [J]. Alzheimers Dement, 2021, 17(2): 255-270. [10] SCALES K, ZIMMERMAN S, MILLER S J. Evidence-based nonpharmacological practices to address behavioral and psychological symptoms of dementia [J]. Gerontologist, 2018, 58(Suppl 1): S88-S102. [11] BAHAR-FUCHS A, MARTYR A, GOH A M, et al. Cognitive training for people with mild to moderate dementia [J]. Cochrane Database Syst Rev, 2019, 3(3): CD013069. [12] SARAGIH I D, TONAPA S I, SARAGIH I S, et al.Effects of cognitive stimulation therapy for people with dementia: a systematic review and meta-analysis of randomized controlled studies [J]. Int J Nurs Stud, 2022, 128: 104181. [13] STRÖHLE A, SCHMIDT D K, SCHULTZ F, et al. Drug and exercise treatment of Alzheimer disease and mild cognitive impairment: a systematic review and meta-analysis of effects on cognition in randomized controlled trials [J]. Am J Geriatr Psychiatry, 2015, 23(12): 1234-1249. [14] VAN DER STEEN J T, SMALING H J, VAN DER WOUDEN J C, et al. Music-based therapeutic interventions for people with dementia [J].Cochrane Database Syst Rev, 2018, 7(7): CD003477. [15] PARK K, LEE S, YANG J, et al.A systematic review and meta-analysis on the effect of reminiscence therapy for people with dementia [J]. Int Psychogeriatr, 2019, 31(11): 1581-1597. [16] WOODS B, O'PHILBIN L, FARRELL E M, et al. Reminiscence therapy for dementia [J].Cochrane Database Syst Rev, 2018, 3(3): CD001120. [17] NAM Y, KIM M, CHANG H S, et al.Drug repurposing with network reinforcement [J]. BMC Bioinformatics, 2019, 20(Suppl 13): 383. [18] DEARDORFF W J, GROSSBERG G T. A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease [J]. Drug Des Devel Ther, 2016, 10: 3267-3279. [19] PARSONS C. Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem [J]. Ther Adv Drug Saf, 2017, 8(1): 31-46. [20] ESHETIE T C, NGUYEN T A, GILLAM M H, et al. A narrative review of problems with medicines use in people with dementia [J]. Expert Opin Drug Saf, 2018, 17(8): 825-836. [21] 田双月, 刘帅, 王志稳. 中重度失智老人居家照护者困扰问题及需求调研 [J]. 中国护理管理, 2019, 19(10): 1502-1507. [22] PULIDO HERRERA E. Location-based technologies for supporting elderly pedestrian in "getting lost" events [J]. Disabil Rehabil Assist Technol, 2017, 12(4): 315-323. [23] AGRAWAL A K, GOWDA M, ACHARY U, et al. Approach to management of wandering in dementia: ethical and legal issue [J].Indian J Psychol Med, 2021, 43(5 Suppl): S53-S59. [24] PECH M, SAUZEON H, YEBDA T, et al.Falls detection and prevention systems in home care for older adults: myth or reality? [J]. JMIR Aging, 2021, 4(4): e29744. [25] HEGDE N, SAZONOV E. SmartStep: a fully integrated, low-power insole monitor[J]. Electronics, 2014, 3(2):381-397. [26] STONE E E, SKUBIC M. Evaluation of an inexpensive depth camera for passive in-home fall risk assessment[C]//2011 5th International Conference on Pervasive Computing Technologies for Healthcare (PervasiveHealth) and Workshops. Ieee, 2011: 71-77. [27] LIVINGSTON G, HUNTLEY J, SOMMERLAD A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission [J].Lancet, 2020, 396(10248): 413-446. [28] CROUS-BOU M, MINGUILLóN C, GRAMUNT N, et al.Alzheimer's disease prevention: from risk factors to early intervention [J]. Alzheimers Res Ther, 2017, 9(1): 71. [29] LANGA K M. Is the risk of Alzheimer's disease and dementia declining? [J]. Alzheimers Res Ther, 2015, 7(1): 34. [30] SPERLING R A, AISEN P S, BECKETT L A, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [J]. Alzheimers Dement, 2011, 7(3): 280-292. [31] WEINTRAUB S, CARRILLO M C, FARIAS S T, et al. Measuring cognition and function in the preclinical stage of Alzheimer's disease [J].Alzheimers Dement(NY), 2018, 4: 64-75. [32] DONOHUE M C, SPERLING R A, SALMON D P, et al.The preclinical Alzheimer cognitive composite: measuring amyloid-related decline [J]. JAMA Neurol, 2014, 71(8): 961-970. [33] KREMEN W S, BECK A, ELMAN J A, et al. Influence of young adult cognitive ability and additional education on later-life cognition [J]. Proc Natl Acad Sci U S A, 2019, 116(6): 2021-2026. [34] NORTON S, MATTHEWS F E, BARNES D E, et al. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data [J]. Lancet Neurol, 2014, 13(8): 788-794. [35] LARSSON S C, TRAYLOR M, MALIK R, et al. Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis [J]. BMJ, 2017, 359: j5375. [36] BERENDSEN A A M, KANG J H, VAN DE REST O, et al. The dietary approaches to stop hypertension diet, cognitive function, and cognitive decline in American older women [J]. J Am Med Dir Assoc, 2017, 18(5): 427-432. [37] TANGNEY C C, LI H, WANG Y, et al. Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons [J]. Neurology, 2014, 83(16): 1410-1416. |
[1] | SUN Li, YIN Weihong, JING Jun, QIAN Xiali. Effects of intraoperative subanesthetic dose of esketamine on early postoperative cognitive dysfunction in elderly patients undergoing spinal surgery [J]. Practical Geriatrics, 2024, 38(10): 1039-1043. |
[2] | . [J]. Practical Geriatrics, 2024, 38(5): 433-437. |
[3] | . [J]. Practical Geriatrics, 2024, 38(5): 438-437. |
[4] | . [J]. Practical Geriatrics, 2024, 38(5): 447-437. |
[5] | GUO Jinhua, SHEN Tiemei, CHEN Ling, CUI Hong, WANG Xiaoxia, HUANG Qiao, HUANG Fang, LI Yun, YANG Manqing. Prevalence and risk factors of cognitive function in elderly inrural areas of Guangdong Province [J]. Practical Geriatrics, 2024, 38(5): 456-437. |
[6] | WEI qian, CAI Yingyuan, WANG Shan,TAN Fuyun, LU Xiaowei. Relationship between serum thyrotropin and risk of cognitive impairment in elderly with normalthyroid function and subclinical hypothyroidism [J]. Practical Geriatrics, 2024, 38(5): 486-437. |
[7] | . [J]. Practical Geriatrics, 2024, 38(5): 512-437. |
[8] | JIAO Linna, LI Baoyi, WANG Qin, HE Jianli. Correlation of white matter lesions and cerebral cortex thickness with cognitive dysfunction after mild stroke in the elderly [J]. Practical Geriatrics, 2024, 38(3): 287-290. |
[9] | . [J]. Practical Geriatrics, 2023, 37(12): 1249-1254. |
[10] | . [J]. Practical Geriatrics, 2023, 37(10): 984-988. |
[11] | . [J]. Practical Geriatrics, 2023, 37(10): 1041-1043. |
[12] | . [J]. Practical Geriatrics, 2023, 37(10): 1059-1063. |
[13] | . [J]. Practical Geriatrics, 2023, 37(9): 869-872. |
[14] | WANG Min, GUO Wen-jun, TANG Zhong-quan, ZHAO Xiao-min, OU Ting, LI Yun-tao. Association between hearing impairment and Alzheimer's disease: a Meta-analysis [J]. Practical Geriatrics, 2023, 37(9): 915-919. |
[15] | LYU Kun, CAO Wen-ping, WANG Yu-hang, ZHAO Chun-sheng, CAO Sheng-wu. Effects of different anesthetic modalities on deep brain stimulation in subthalamic nucleus for Parkinson's disease [J]. Practical Geriatrics, 2023, 37(9): 938-942. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
|